SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Theodore Roosevelt — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientTheodore Roosevelt
Date of birth1858-10-27
IdentifiersMRN HR-NI012-SYN-TD; SSN (made up) 000-12-6157
Document date1882-03-09
AuthorAmos Kettering, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for primary care visit for frequent wheeze, night cough, and breathlessness during training. [S]

Objective

FEV1 before bronchodilator: 3.2 L (low); FEV1 percent predicted: 72% (low); FVC: 4.8 L; FEV1/FVC ratio: 0.67 (low); FEV1 after bronchodilator: 3.74 L; Asthma Control Test: 13; PHQ-2: 0. [S]

Vital Signs

DateMeasureValueUnitProvenance
1882-03-09Body height175cmS
1882-03-09Body weight72kgS
1882-03-09Body mass index (BMI) [Ratio]23.5kg/m2S
1882-03-09Systolic blood pressure118mm[Hg]S
1882-03-09Diastolic blood pressure72mm[Hg]S
1882-03-09Heart rate84/minS
1882-03-09Respiratory rate18/minS
1882-03-09Body temperature36.8CelS
1882-03-09Oxygen saturation in Arterial blood by Pulse oximetry96%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1882-03-09FEV1 --pre bronchodilation3.2L>=3.65 LLowS
1882-03-09FEV1 measured/predicted72%>=80%LowS
1882-03-09Forced vital capacity [Volume] Respiratory system4.8L>=4.4 LNormalS
1882-03-09FEV1/FVC0.67{ratio}>=0.72LowS
1882-03-09FEV1 --post bronchodilation3.74L>=3.65 LNormalS
1882-03-09Total score [ACT]13{score}S
1882-03-09Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Albuterol 90 mcg/actuation inhaler, two inhalations as needed for wheeze (bought after an urgent care visit; used most days before intake)Two inhalations every 4 hours as neededRespiratory tract route1881-12-15 to 1882-03-09stoppedS
Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenanceTwo inhalations twice daily, with a spacer, rinsing the mouth afterwardsRespiratory tract route1882-03-09activeS
Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in totalOne inhalation as needed, repeated after a few minutes if needed; maximum 12 inhalations a day including maintenance dosesRespiratory tract route1882-03-09activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Moderate persistent asthma, uncontrolled at intake, with reversible airflow obstruction on spirometry; synthetic modern diagnosis linked to his documented lifelong asthmaactiveconfirmed J45.40S — Synthetic modern classification confirmed by spirometry; the historical asthma is D and its persistence into adulthood is R.
Myopia, both eyes, corrected with glasses since boyhoodactiveconfirmed H52.13S — Synthetic modern entry linked to his documented near-sightedness.

Assessment

Plan of Treatment